📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cytena

1.1 - Company Overview

Cytena Logo

Cytena

Headquarter: Germany
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of single-cell printing and isolation technologies for cell research and professional diagnostics, offering the cy-Clone device to separate single cells for biologics development and genetic analysis in cancer and stem cell research, and instruments including UP.SIGHT, C.SIGHT 2.0, B.SIGHT, CELLCYTE X, C.WASH PLUS, and the C.LIVE Caspase-3 Green NucView assay.

Products and services

  • UP.SIGHTâ„¢: A research-grade device for cell line development that delivers proof of monoclonality, enables colony tracking, quantifies confluency, and measures titer for rigorous clone verification
  • B.SIGHTâ„¢: A microbiology-focused system enabling rapid microbial single-cell isolation and cultivation, supporting microbiome research and synthetic biology by efficiently capturing and growing individual microbes
  • CELLCYTE Xâ„¢: A live-cell imaging system that allows real-time observation of cell kinetics in live cells for time-resolved visualization.

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Cytena

Xceleron Logo

Xceleron

HQ: United States Website
  • Description: Provider of Accelerator Mass Spectrometry (AMS) services delivering ultra-sensitive analytical solutions for drug development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Xceleron company profile →
Enza Biotech Logo

Enza Biotech

HQ: Sweden Website
  • Description: Provider of research and development of renewable surfactants using carbohydrate-based chemistry, operating at the intersection of science and business to support the transition from a fossil-dependent to a biobased society; founded in 2012 and based at Chemical Center in Lund, Southern Sweden.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Enza Biotech company profile →
Signal Pharmaceuticals Logo

Signal Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical solutions, headquartered in San Diego, California.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Signal Pharmaceuticals company profile →
ProAxsis Logo

ProAxsis

HQ: United Kingdom Website
  • Description: Provider of laboratory-based immunoassays and rapid point-of-care tests for the capture, detection, and measurement of active protease biomarkers of disease, incorporating patented ProteaseTags smart molecules that selectively trap active proteases and deliver a visual readout in complex biological samples.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ProAxsis company profile →
Biocoat Logo

Biocoat

HQ: United States Website
  • Description: Provider of custom-engineered biomaterial coatings for medical devices, specializing in lubricious hydrophilic coatings that deliver lubricity, durability, and low particulate counts. Services include contract coating, custom polymer synthesis, and reagent fulfillment, with specialized hydrophilic solutions for neurovascular and cardiovascular devices.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biocoat company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Cytena

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cytena

2.2 - Growth funds investing in similar companies to Cytena

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Cytena

4.2 - Public trading comparable groups for Cytena

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Cytena

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Cytena

What does Cytena do?

Cytena is a provider of single-cell printing and isolation technologies for cell research and professional diagnostics, offering the cy-Clone device to separate single cells for biologics development and genetic analysis in cancer and stem cell research, and instruments including UP.SIGHT, C.SIGHT 2.0, B.SIGHT, CELLCYTE X, C.WASH PLUS, and the C.LIVE Caspase-3 Green NucView assay.

Who are Cytena's competitors?

Cytena's competitors and similar companies include Xceleron, Enza Biotech, Signal Pharmaceuticals, ProAxsis, and Biocoat.

Where is Cytena headquartered?

Cytena is headquartered in Germany.

How many employees does Cytena have?

Cytena has 1,000 employees 🔒.

When was Cytena founded?

Cytena was founded in 2010 🔒.

What sector and industry vertical is Cytena in?

Cytena is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Cytena

Who are the top strategic acquirers in Cytena's sector and industry

Top strategic M&A buyers and acquirers in Cytena's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Cytena?

Top strategic M&A buyers groups and sectors for Cytena include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Cytena's sector and industry vertical

Which are the top PE firms investing in Cytena's sector and industry vertical?

Top PE firms investing in Cytena's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Cytena's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cytena's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Cytena's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cytena include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Cytena's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cytena?

The key public trading comparables and valuation benchmarks for Cytena include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Cytena for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cytena with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cytena's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cytena with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cytena's' sector and industry vertical?

Access recent funding rounds and capital raises in Cytena's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cytena